Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre

被引:44
|
作者
Gual, A. [1 ]
Mascaro, J. M., Jr. [1 ]
Rojas-Farreras, S. [2 ]
Guilabert, A. [1 ]
Julia, M. [1 ]
Iranzo, P. [1 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Dept Dermatol, Barcelona, Spain
[2] IMS Hlth, Barcelona, Spain
关键词
COHORT ANALYSIS; PROGNOSIS; REGION; RISK;
D O I
10.1111/jdv.12065
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Prognosis of patients with bullous pemphigoid (BP) is controversial, with a 1-year mortality rate ranging from 6% to 48%. Objective To determine the mortality rate of a large cohort of patients with BP and to identify prognostic factors associated with early mortality. Methods Patients diagnosed with BP between January 1, 1990 and December 31, 2010 in a referral unit for blistering skin diseases at a university hospital in Spain were studied retrospectively. Outcome measures were mortality rate during the first year after diagnosis, standardized mortality rate and poor prognostic factors. Results A total of 101 patients were included in the study. The mean patient age at diagnosis was 77.8 years, and 52 (51.5%) were men. Overall mortality during the first year was 12.9%. We found a standardized mortality ratio of 2.33 [CI95 =( )(1.25-4.03)]. Advanced age (patient group >80 years old) was the only risk factor for lethal outcome found, with a multivariate risk estimate of 1.09 [CI95 =( )(1.02-1.16)]. No significant association with mortality was detected for comorbidities, hospitalization history or treatment received for BP. Conclusions We found an increased mortality of our BP patients compared with the general population. The mortality rate of BP patients was 2.3 times the expected rate. Observed mortality rate was lower than described in previous European studies. Advanced age impacts the prognosis of patients with BP. Specific treatment for BP appeared not to influence survival.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 50 条
  • [41] Hospitalization and mortality in Asian autoimmune bullous dermatosis patients: A 17-year retrospective study
    Amonchaisakda, Nuntouchaporn
    Rujitharanawong, Chuda
    Tuchinda, Papapit
    Kulthanan, Kanokvalai
    Chularojanamontri, Leena
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (05)
  • [42] Readmission, mortality, and first-year medical costs after stroke
    Lee, Hsuei-Chen
    Chang, Ku-Chou
    Huang, Yu-Ching
    Hung, Jen-Wen
    Chiu, Hsien-Hsueh Elley
    Chen, Jin-Jong
    Lee, Tsong-Hai
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (12) : 703 - 714
  • [43] Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up
    Ahmed, A. Razzaque
    Shetty, Shawn
    Kaveri, Srini
    Spigelman, Zachary S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (04) : 700 - +
  • [44] Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid
    Sardy, Miklos
    Kostaki, Dimitra
    Varga, Rita
    Peris, Ketty
    Ruzicka, Thomas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (05) : 748 - 753
  • [45] Impact of neurological diseases on the prognosis of bullous pemphigoid: A retrospective study of 178 patients
    Chevalier, V.
    Barbe, C.
    Reguiai, Z.
    Plee, J.
    Grange, F.
    Bernard, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (03): : 179 - 186
  • [46] Efficacy and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients
    Moghadam, Parna
    Tancrede, Emmanuelle
    Bouaziz, Jean-David
    Kallout, Julien
    Bedane, Christophe
    Begon, Edouard
    Bourgault-Villada, Isabelle
    Calugareanu, Andreea
    Dereure, Olivier
    Jendoubi, Fatma
    Pham-Ledard, Anne
    Ingen-Housz-Oro, Saskia
    Picard-Dahan, Catherine
    Viguier, Manuelle
    Mahevas, Thibault
    Jachiet, Marie
    Charvet, Estelle
    Cassius, Charles
    Alexandre, Marina
    Lepelletier, Clemence
    Groupe Bulles French Society Dermatology
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : 244 - 246
  • [47] Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study
    Zhang, Li-Ming
    Wu, Jian
    Xiao, Ting
    Jin, Guang-Yu
    Li, Jiu-Hong
    Geng, Long
    He, Chun-Di
    Gao, Xing-Hua
    Chen, Hong-Duo
    EUROPEAN JOURNAL OF DERMATOLOGY, 2013, 23 (01) : 94 - 98
  • [48] One-year mortality rate in bullous pemphigoid - significant correlation of autoantibody levels against BP180 at time of diagnosis
    Monshi, B.
    Piringer, B.
    Schmidt, M.
    Rappersberger, K.
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (03) : e21 - e21
  • [49] Treatment of bullous pemphigoid with dapsone: Retrospective study of thirty-six cases
    Bouscarat, F
    Chosidow, O
    PicardDahan, C
    Sakiz, V
    Crickx, B
    Prost, C
    Roujeau, JC
    Revuz, J
    Belaich, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (04) : 683 - 684
  • [50] Immunological features and factors associated with mucocutaneous bullous pemphigoid - a retrospective cohort study
    Staender, Sascha
    Schmidt, Enno
    Zillikens, Detlef
    Ludwig, Ralf J.
    Kridin, Khalaf
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (09): : 1289 - 1295